What Are the Symptoms of Skin Cancer?

Translate to Spanish or other 102 languages!

Talk to your doctor if you notice changes in your skin such as a new growth, a sore that doesn’t heal, a change in an old growth, or any of the A-B-C-D-Es of melanoma. Image for illustration purposes
Talk to your doctor if you notice changes in your skin such as a new growth, a sore that doesn’t heal, a change in an old growth, or any of the A-B-C-D-Es of melanoma. Image for illustration purposes

Mega Doctor News

- Advertisement -

CDC – A change in your skin is the most common sign of skin cancer. This could be a new growth, a sore that doesn’t heal, or a change in a mole Not all skin cancers look the same.

For melanoma specifically, a simple way to remember the warning signs is to remember the A-B-C-D-Es of melanoma—

  1. Asymmetrical: Does the mole or spot have an irregular shape with two parts that look very different?
  2. Border: Is the border irregular or jagged?
  3. Color: Is the color uneven?
  4. Diameter: Is the mole or spot larger than the size of a pea?
  5. Evolving: Has the mole or spot changed during the past few weeks or months?

Talk to your doctor if you notice changes in your skin such as a new growth, a sore that doesn’t heal, a change in an old growth, or any of the A-B-C-D-Es of melanoma.

- Advertisement -

More Information

Information Source:  CDC

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.
- Advertisement -